Search
for
Sort by
Research 31–60 of 1000+
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- New insights into alopecia areata during COVID‐19 pandemic: When infection or vaccination could play a role
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
- Neurological post‐acute sequelae of SARS‐CoV‐2 infection
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- ACUTE TELOGEN EFFLUVIUM FOLLOWING SARS-COV-2 INFECTION: A RARE PEDIATRIC CASE
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
- Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development